Panitumumab and irinotecan versus irinotecan alone for patients with KRAS wild-type, fluorouracil-resistant advanced colorectal cancer (PICCOLO): a prospectively stratified randomised trialMichel Seymour, Philip Quirke, Sarah Brown et al.|The Lancet Oncology|2013Cited by 392
Efficacy of Reduced-Intensity Chemotherapy With Oxaliplatin and Capecitabine on Quality of Life and Cancer Control Among Older and Frail Patients With Advanced Gastroesophageal CancerPeter S Hall, Pavel Bezecny, Sharon Ruddock et al.|JAMA Oncology|2021Cited by 196
A randomised phase III trial of the pharmacokinetic biomodulation of irinotecan using oral ciclosporin in advanced colorectal cancer: Results of the Panitumumab, Irinotecan & Ciclosporin in COLOrectal cancer therapy trial (PICCOLO)Gary Middleton, Michel Seymour, Sarah Brown et al.|European Journal of Cancer|2013Cited by 24